Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : View from the Center and Left -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (18242)	5/10/2006 4:01:14 PM
From: epicure	Respond to of 543453

Not necessarily. The mother herself could have been at more risk from childbirth than from the abortion. It's not only a value judgment - which is why church folk shouldn't be providing health care except to people who choose to have their health care impacted in that very special way.

To: Ilaine who wrote (18242)	5/10/2006 7:14:24 PM
From: thames_sider	Respond to of 543453

Well, says he, there's always this new wonder medicine. I assume this is another accurate article from this reliable source. Or if not, it probably soon will be. New 'Anti-Abortion Pill' Kills Mother, Leaves Fetus Alive Pro-life advocates celebrated approval of the new anti-abortion drug UR-86 by the Food and Drug Administration Tuesday, calling it a "safe and effective method" for terminating pregnant women while leaving their unborn children unharmed. Pfizer, manufacturer of UR-86—dubbed the "last-morning-ever pill"—said the drug is intended only for occasions when the mind-set or politics of the mother threaten the life of the fetus. "This drug is designed for extreme cases in which the mother cannot or should not be saved, or when her health has been placed before that of her unborn child," Pfizer spokesman Anthony Wright said. The orally ingested drug first tests for the presence of a fetus. If the outcome is positive, a near-lethal dose of barbiturates is released, which induces a coma in the expectant mother until the child is born, at which point a second, fatal dose is released. The FDA's approval came after months of clinical trials firmly established that the fetus would be nourished and protected in the womb of the near-deceased UR-86 user. ... theonion.com